Intravenous antiplatelet therapy may improve heart function in cardiogenic shock patients compared to oral medication
Patients who survive cardiogenic shock after a heart attack are among the highest-risk patients and have a significant risk of developing heart failure. Any improvement of heart function should reduce their risk of developing heart failure in the long term.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Discontinuing statins generally safe for older adults without heart disease
United Kingdom
-
Five AI models tackled 227 pharmacy exam questions. Here's where they struggled
United Kingdom
-
An inside look at a molecular switch that triggers inflammation
United Kingdom
-
Few meet major clinical response criteria after treatment escalation for lupus
United Kingdom
-
New blood test claims to detect 50+ cancers before symptoms—but there's no proof it reduces cancer death risk
United Kingdom
-
Scientists identify inhibition of a specific enzyme as a promising target to treat pancreatic cancer
United Kingdom
-
Researchers reveal how inhaled nanoplastics trigger lung inflammation
United Kingdom
-
Intensive blood pressure therapy did not cut cardiovascular events in adults with diabetes
United Kingdom